Excess fat in brain immune cells weakens defenses against Alzheimer’s. Blocking fat storage restored their ability to fight disease. For many years, scientists believed that fat in the brain had ...

Why experiencing cognitive decline isn't the end of the road, and how new research shines a light on the role of accessible ...

A senior Novo Nordisk executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for ...

New Alzheimer's drugs slow cognitive decline by 27% but cause dangerous brain swelling in 40% of patients, sparking medical ...

Dementia has become one of the world’s most pressing health challenges. Millions of people live with the condition, and the ...

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming ...

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between ...

A new generation of Alzheimer’s blood tests could speed up diagnosis and access to care—but they also raise thorny questions ...

The global incidence of Alzheimer’s is increasing at a rapid rate. In the U.S., more people than ever are being diagnosed ...

TSPO levels rise early in Alzheimer’s and persist throughout disease. Targeting this biomarker could open new treatment options. TSPO, a major marker of brain inflammation, may offer a way to detect ...